clinical trial · NCT07207707
A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies
Solid Tumor MalignanciesKQB548
brief summary
The goal of this trial is to learn if KQB548 works to treat patients with advanced solid malignancies with a KRAS G12D mutation. It will also learn about the safety of KQB548. The main questions it aims to answer are: * What is the safe dose of KQB548? * Does KQB548 decrease the size of the tumor? * What happens to KQB548 in the body?
started
Sep 16, 2025
primary completion
Sep 1, 2026
completion
Mar 1, 2027
last updated
Mar 13, 2026
official title
A Phase 1a, Open-label, Multicenter, Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of KQB548 in Participants With Advanced Solid Malignancies With a KRAS G12D Mutation
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol